Literature DB >> 21755637

Biomedical loopholes, distrusted state, and the politics of HIV/AIDS "cure" in Nigeria.

Ebenezer Obadare1, Iruka N Okeke.   

Abstract

As socio-medical phenomena, epidemics are revealing of the cultures in which they are experienced. The HIV/AIDS epidemic in Africa exposes antecedent tensions between state and society, and, on a broader canvas, between the global north and south. As a contribution to the emerging literature on the social ramifications of HIV/AIDS, this article examines the saga of the Nigerian physician and immunologist, Dr Jeremiah Abalaka, who like other innovators in sub-Saharan Africa claims to have developed a curative HIV vaccine. Whilst articulating the social conditions that enabled Abalaka to thrive, the article explores the marked differences in the reaction to his "discovery" among state representatives, the scientific establishment, the general public, people living with HIV, and the media. Finally, the article valorizes the emergence of new actors in the African health sector, and the diversity of strategies used by ordinary people to achieve and maintain wellness.

Entities:  

Mesh:

Year:  2011        PMID: 21755637     DOI: 10.1093/afraf/adr001

Source DB:  PubMed          Journal:  Afr Aff (Lond)        ISSN: 0001-9909


  3 in total

1.  Social and ethical implications of HIV cure research.

Authors:  Joseph D Tucker; Stuart Rennie
Journal:  AIDS       Date:  2014-06-01       Impact factor: 4.177

Review 2.  Traditional, complementary, and alternative medical cures for HIV: rationale and implications for HIV cure research.

Authors:  Xin Pan; Alice Zhang; Gail E Henderson; Stuart Rennie; Chuncheng Liu; Weiping Cai; Feng Wu; Joseph D Tucker
Journal:  Glob Public Health       Date:  2017-12-13

3.  Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa.

Authors:  Keymanthri Moodley; Theresa Rossouw; Ciara Staunton; Christopher J Colvin
Journal:  BMC Med Ethics       Date:  2016-04-30       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.